annual cash & cash equivalents:
$102.01M+$30.73M(+43.11%)Summary
- As of today (June 22, 2025), BPMC annual cash & cash equivalents is $102.01 million, with the most recent change of +$30.73 million (+43.11%) on December 31, 2024.
- During the last 3 years, BPMC annual cash & cash equivalents has fallen by -$107.93 million (-51.41%).
- BPMC annual cash & cash equivalents is now -85.10% below its all-time high of $684.64 million, reached on December 31, 2020.
Performance
BPMC Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$122.25M+$20.23M(+19.83%)Summary
- As of today (June 22, 2025), BPMC quarterly cash & cash equivalents is $122.25 million, with the most recent change of +$20.23 million (+19.83%) on March 31, 2025.
- Over the past year, BPMC quarterly cash & cash equivalents has increased by +$8.92 million (+7.87%).
- BPMC quarterly cash & cash equivalents is now -82.49% below its all-time high of $697.97 million, reached on March 31, 2021.
Performance
BPMC quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BPMC Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.1% | +7.9% |
| 3 y3 years | -51.4% | +228.6% |
| 5 y5 years | -10.5% | -67.4% |
BPMC Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -51.4% | +43.1% | -58.0% | +228.6% |
| 5 y | 5-year | -85.1% | +43.1% | -82.5% | +228.6% |
| alltime | all time | -85.1% | +5034.1% | -82.5% | +228.6% |
BPMC Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $122.25M(+19.8%) |
| Dec 2024 | $102.01M(+43.1%) | $102.01M(+14.2%) |
| Sep 2024 | - | $89.36M(+63.1%) |
| Jun 2024 | - | $54.77M(-51.7%) |
| Mar 2024 | - | $113.33M(+59.0%) |
| Dec 2023 | $71.29M(-40.5%) | $71.29M(+27.4%) |
| Sep 2023 | - | $55.97M(-25.9%) |
| Jun 2023 | - | $75.53M(-55.5%) |
| Mar 2023 | - | $169.72M(+41.8%) |
| Dec 2022 | $119.71M(-43.0%) | $119.71M(-58.9%) |
| Sep 2022 | - | $291.43M(+68.1%) |
| Jun 2022 | - | $173.40M(+366.1%) |
| Mar 2022 | - | $37.20M(-82.3%) |
| Dec 2021 | $209.95M(-69.3%) | $209.95M(-62.1%) |
| Sep 2021 | - | $553.59M(+3.6%) |
| Jun 2021 | - | $534.32M(-23.4%) |
| Mar 2021 | - | $697.97M(+1.9%) |
| Dec 2020 | $684.64M(+500.9%) | $684.64M(+21.1%) |
| Sep 2020 | - | $565.22M(+95.8%) |
| Jun 2020 | - | $288.68M(-23.1%) |
| Mar 2020 | - | $375.17M(+229.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $113.94M(+67.4%) | $113.94M(+27.7%) |
| Sep 2019 | - | $89.24M(+8.3%) |
| Jun 2019 | - | $82.42M(+3.8%) |
| Mar 2019 | - | $79.39M(+16.6%) |
| Dec 2018 | $68.06M(-83.0%) | $68.06M(-13.4%) |
| Sep 2018 | - | $78.64M(-33.2%) |
| Jun 2018 | - | $117.75M(-12.7%) |
| Mar 2018 | - | $134.89M(-66.3%) |
| Dec 2017 | $400.30M(+668.8%) | $400.30M(+598.3%) |
| Sep 2017 | - | $57.33M(-37.2%) |
| Jun 2017 | - | $91.35M(+62.1%) |
| Mar 2017 | - | $56.36M(+8.2%) |
| Dec 2016 | $52.07M(-68.0%) | $52.07M(-30.0%) |
| Sep 2016 | - | $74.40M(-32.0%) |
| Jun 2016 | - | $109.39M(-10.6%) |
| Mar 2016 | - | $122.29M(-24.8%) |
| Dec 2015 | $162.71M(+244.4%) | $162.71M(-9.5%) |
| Sep 2015 | - | $179.78M(-7.1%) |
| Jun 2015 | - | $193.59M(+284.9%) |
| Mar 2015 | - | $50.30M(+6.5%) |
| Dec 2014 | $47.24M(+2277.5%) | $47.24M |
| Dec 2013 | $1.99M | - |
FAQ
- What is Blueprint Medicines annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Blueprint Medicines?
- What is Blueprint Medicines annual cash & cash equivalents year-on-year change?
- What is Blueprint Medicines quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Blueprint Medicines?
- What is Blueprint Medicines quarterly cash & cash equivalents year-on-year change?
What is Blueprint Medicines annual cash & cash equivalents?
The current annual cash & cash equivalents of BPMC is $102.01M
What is the all time high annual cash & cash equivalents for Blueprint Medicines?
Blueprint Medicines all-time high annual cash & cash equivalents is $684.64M
What is Blueprint Medicines annual cash & cash equivalents year-on-year change?
Over the past year, BPMC annual cash & cash equivalents has changed by +$30.73M (+43.11%)
What is Blueprint Medicines quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of BPMC is $122.25M
What is the all time high quarterly cash & cash equivalents for Blueprint Medicines?
Blueprint Medicines all-time high quarterly cash & cash equivalents is $697.97M
What is Blueprint Medicines quarterly cash & cash equivalents year-on-year change?
Over the past year, BPMC quarterly cash & cash equivalents has changed by +$8.92M (+7.87%)